Dhanak Dashyant 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Feb 20, 2024
Insider Transaction Report
Form 4
Dhanak Dashyant
EVP & Chief Scientific Officer
Transactions
- Award
Common Stock
2024-02-15+17,275→ 158,175 total - Award
Stock Option (Right to Buy)
2024-02-15+69,100→ 69,100 totalExercise: $15.92Exp: 2034-02-14→ Common Stock (69,100 underlying)
Footnotes (2)
- [F1]The reporting person was awarded 17,275 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in three equal installments on each of February 15, 2025, February 15, 2026 and February 15, 2027.
- [F2]This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in equal monthly installments over four years, beginning on March 15, 2024.